A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Renaissance Technologies LLC holds 209,600 shares of CNTA stock, worth $3.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
209,600
Previous 173,700 20.67%
Holding current value
$3.67 Million
Previous $1.57 Million 113.71%
% of portfolio
0.01%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$8.58 - $16.99 $308,022 - $609,941
35,900 Added 20.67%
209,600 $3.35 Million
Q2 2024

Aug 09, 2024

SELL
$8.04 - $11.87 $362,603 - $535,337
-45,100 Reduced 20.61%
173,700 $1.57 Million
Q1 2024

May 13, 2024

BUY
$6.73 - $12.2 $223,436 - $405,040
33,200 Added 17.89%
218,800 $2.47 Million
Q4 2023

Feb 13, 2024

BUY
$5.52 - $8.03 $731,400 - $1.06 Million
132,500 Added 249.53%
185,600 $1.48 Million
Q3 2023

Nov 14, 2023

BUY
$6.01 - $8.24 $112,988 - $154,912
18,800 Added 54.81%
53,100 $344,000
Q2 2023

Aug 11, 2023

BUY
$3.68 - $6.9 $68,448 - $128,340
18,600 Added 118.47%
34,300 $212,000
Q1 2023

May 12, 2023

BUY
$3.03 - $4.0 $47,571 - $62,800
15,700 New
15,700 $60,000

Others Institutions Holding CNTA

About Centessa Pharmaceuticals plc


  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.65B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.